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Surface morphology and in vitro 
leachability of soft liners modified by 
the incorporation of antifungals for 
denture stomatitis treatment
Objective: To evaluate the surface morphology and in vitro leachability of 
temporary soft linings modified by the incorporation of antifungals in minimum 
inhibitory concentrations (MIC) for Candida albicans biofilm. Methodology: 
Specimens of soft lining materials Softone and Trusoft were made without 
(control) or with the addition of nystatin (Ny), miconazole (Mc), ketoconazole 
(Ke), chlorhexidine diacetate (Chx), or itraconazole (It) at their MIC for C. 
albicans biofilm. The surface analyses were performed using Confocal laser 
scanning microscopy after 24 h, 7 days, or 14 days of immersion in distilled 
water at 37ºC. In vitro leachability of Chx or Ny from the modified materials 
was also measured using Ultraviolet visible spectroscopy for up to 14 days 
of immersion in distilled water at 37ºC. Data (μg/mL) were submitted to 
ANOVA 1-factor/Bonferroni (α=0.05). Results: Softone had a more irregular 
surface than Trusoft. Morphological changes were noted in both materials with 
increasing immersion time, particularly, in those containing drugs. Groups 
containing Chx and It presented extremely porous and irregular surfaces. 
Both materials had biexponential release kinetics. Softone leached a higher 
concentration of the antifungals than Trusoft (p=0.004), and chlorhexidine 
was released at a higher concentration than nystatin (p<0.001). Conclusions: 
The surface of the soft lining materials changed more significantly with the 
addition of Chx or It. Softone released a higher concentration of drugs than 
Trusoft did, guiding the future treatment of denture stomatitis.
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Introduction
Denture-induced stomatitis is considered the most 
common fungal infection among denture wearers.1 
This pathology is primarily associated with infection 
by Candida albicans, which is found in 50 to 98% of all 
cases.2-3 Treatments for denture stomatitis are varied 
and include topical and systemic antifungal therapy, 
oral hygiene care, procedures for denture cleaning 
and disinfection, replacement of old dentures, removal 
of anatomical irregularities, reestablishment of 
nontraumatic occlusion, and nutritional restitution.1-5 
Additionally, to protect and preserve the mucosal 
integrity, the patients should sleep without the 
dentures.1,5,6  Studies in vivo have reported that the 
nocturnal wear increases the colony counts of C. 
albicans, which reinforces that such habit can induce 
denture stomatitis.6
Topical antifungal agents are widely used in the 
therapy for this condition.1 However, their effectiveness 
can be compromised by many factors, including 
lack of patient perception of the infection, costs 
required for the medication, continuous denture wear, 
unpleasant taste, and patient compliance in strictly 
following the posology.2 Furthermore, salivary flow, 
tongue movements, and swallowing decrease drug 
concentration to subtherapeutic doses.2 However, 
systemic administration of antifungal agents should 
be carefully administered these drugs can induce 
hepatotoxic and nephrotoxic effects.4
Candida spp. colonization is predominantly more 
observed on the internal surfaces of removable 
dentures than on denture-bearing epithelium2,3,5 
due to the high affinity between microorganisms 
and acrylic resin.7 It has been demonstrated that 
the average depth of C. albicans in denture base 
resins varies according to the time of exposure to 
fungal contamination, reaching 631 μm at 21 days.7 
Therefore, the treatment of denture stomatitis should 
focus on dentures, which may act as the primary 
source of mucosal reinfection.3,5 Since denture base 
acrylic resin is likely to be penetrated by Candida, 
especially in recurrent denture-induced stomatitis, 
it was suggested the removal of the at least a 
1-mm layer of contaminated resin from the infected 
denture-fitting surfaces.7 In this regard, incorporation 
of antifungal agents into denture base materials for 
gradual release to the oral cavity8 can prevent biofilm 
accumulation,8 inhibit C. albicans colonization,8,9 and 
thus, contribute to the treatment of denture-induced 
stomatitis.
In temporary soft lining materials, this modification 
has some advantages: reduction of trauma caused by 
the rigid internal surface of heat-cured acrylic resin 
of removable dentures; elimination of contact of the 
contaminated surface with oral tissues that leads to 
the reinfection cycle; and action of antifungal drugs 
incorporated in the material directly on infected 
tissues.8-9 In this context, denture stomatitis might 
be treated for two weeks, a period similar to the 
treatment with conventional topical antifungals 
and maximum period tolerated by these temporary 
soft materials due to their degradation and gradual 
stiffening. Since this treatment option does not depend 
on patient compliance,8-9 it may be especially beneficial 
for older patients with physical or mental disorders, 
or in institutional settings, where patients and staff 
cannot follow all recommended instructions to achieve 
a successful treatment.2
Bueno,  et  a l . 10 (2015) determined,  by 
spectrophotometric analysis using tetrazolium salt 
reduction assay (XTT), the concentrations able to 
inhibit 90% or more of C. albicans growth (minimal 
inhibitory concentrations – MICs) for up to 14 days 
for five drugs when incorporated into two temporary 
soft denture liners (Softone and Trusoft). However, 
before using this protocol as a therapeutic option in 
individuals with denture stomatitis, it is necessary to 
obtain a polymeric matrix modified by the addition 
of antifungals that simultaneously does not present 
altered physical11,12 and mechanical13-15 properties and 
is effective in drug release.
The size, molecular weight, dispersion, and 
concentration of drug particles in the polymeric matrix 
and the drug properties of diffusion and solubilization 
in the medium over time are important factors 
influencing drug release.16 In addition to the important 
characteristics of the polymeric matrix used as vehicle 
for release, factors as polymer micromorphology, 
permeability, porosity, and drug-matrix interaction 
also influence the release patterns.16 Therefore, this 
study evaluated the surface morphology and in vitro 
leachability of temporary soft linings SoftoneTM (S) 
and TrusoftTM (T) modified by the incorporation of 
antifungals in their MICs for C. albicans biofilm. The 
following hypotheses were tested: 1. The incorporation 
of antifungals in the temporary soft linings would 
cause changes in their surface morphology, yielding 
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different roughness values; 2. The materials would 
release different concentrations of antifungals; and 
3. The drugs would present different mechanisms of 
release from both polymeric matrices.
Methodology
Materials
The temporary soft linings evaluated in this study 
are presented in Figure 1. The antifungal drugs and 
their MICs against C. albicans biofilm determined in 
a previous study10 are shown in Figure 2. MICs are 
presented as antifungal powder to each gram of soft 
lining material.
Specimen preparation
The amounts of antifungal powder (Figure 2) were 
manually mixed to the powder of each soft lining until 
a homogeneous mixture was achieved.16 The liquids 
of the materials were then added and the material 
was mixed following the manufacturers’ instructions 
(Figure 1). The material was then inserted in stainless 
steel molds and kept in place during the setting time 
recommended by the manufacturer (Figure 1).
Confocal laser scanning microscopy (CLSM)
Specimens (n=3; 10×5×4 mm) of the soft 
materials modified or not (control) by the addition 
of antifungals and of the control were fabricated and 
individually stored in distilled water at 37ºC during 24 
h, 7 days, or 14 days. They were then dry-stored in 
an oven at 37ºC for additional 48 h.
The specimens were initially observed at 5× 
magnification to select the most representative area. 
Next, a total area of 1280 µm2 of each specimen was 
observed at 10× magnification, using green laser at 
a spectral range of 405 nm. The surface roughness, 
recorded as the Ra (mean roughness) parameter, 
was analyzed along three randomly drawn lines (cut 
off lambda C 80 µm). Small peaks and noises were 
removed by a Gaussian filter, and data were processed 
using software OLS 4000-BSW; Olympus. Data (RA) 
were submitted to ANOVA 3-factors/Bonferroni 
(α=0.05).
In vitro leachability
To prepare the stock solutions (1,000 µg/mL), Chx 
was solubilized in methanol and Ny was dissolved 
in dimethyl formamide/methanol (1:10 v/v). The 
analytic solutions (0 to 25 µg/mL or 0 to 20 µg/mL) 
were then prepared to achieve the calibration curves 
of Chx and Ny, respectively. A mixture of reagents 
was added to the analytic solutions changing its color 
to orange (Chx) according to the method proposed 
by Holbrook17 (1958) or to pink (Ny) in agreement 
with the method by Amer and Habeeb18 (1975) with 
saturation proportional to the drug concentration in 
the sample. Before the analyses, the solutions passed 
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*According to the MSDS provided by the manufacturer.
Figure 1- Soft lining materials chosen for this study
Drug/Acronym Batch MIC for each g of material Manufacturer
Nystatin (Ny) 12030665B 0.032 g Pharmanostra, Rio de Janeiro, RJ, Brazil
Miconazole (Mc) 1207033303 0.256 g Galena Química e Farmacêutica Ltda., Campinas, SP, Brazil
Ketoconazole (Ke) 1211004307 0.128 g Galena Química e Farmacêutica Ltda., Campinas, SP, Brazil
Chlorhexidine (Chx) 206986-79-0 0.064 g Acros Organics, Morris Plains, NJ, USA
Itraconazole (It) 1209003409 0.256 g Galena Química e Farmacêutica Ltda., Campinas, SP, Brazil
Figure 2- Antifungal agents and the previously determined minimum inhibitory concentrations for the biofilm of C. albicans
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through a filter with 0.45-µm pore size. Readings 
were performed in sextuplicate in increasing order 
of concentration using a UV-Vis spectrophotometer 
(Genesys 10 UV scanning; Thermo scientific) at 480 
nm and 520 nm for Chx and Ny analyses, respectively.
Specimens (n=6; 50-mm diameter × 2-mm 
thickness) of soft materials containing Chx and Ny or 
not (control) were fabricated and individually stored in 
flasks with 50 mL of distilled water at 37ºC for up to 
14 days. For Chx, the volume of distilled water used 
for immersion of specimens was sufficient to maintain 
the sink conditions of the medium. Since Ny is nearly 
insoluble in water, it was necessary to add 2% (1 g) 
of surfactant sodium lauryl sulfate. This surfactant 
caused a little impact on drug release.
Daily, aliquots of 1 mL of each storage solution of 
specimens were collected to analyze the drug release 
from the soft materials. This aliquot received addition 
of the same reagents, following the protocols used 
for preparing analytical solutions. After each day, the 
same volume of the aliquot removed for analysis was 
refilled with an equal volume of distilled water without 
or with 2% of sodium lauryl sulfate in the case of Ny. 
Quantification of drug concentration released from the 
materials was performed by using the linear regression 
equations obtained from the calibration curves. The 
percentage of daily release was estimated compared 
to the initial quantity of drug added to the specimens, 
and the release profile was obtained compared to the 
total period of 14 days. Data (μg/mL) were submitted 
to ANOVA 1-factor/Bonferroni (α=0.05).
The release kinetics was also mathematically 
analyzed by adjusting the experimental data to 
the monoexponential model (Equation 1), to the 
biexponential model (Equation 2), to the zero 
order model (Equation 3), and to the Weibull model 
(Equation 4), considering the results of the model 
selection criteria (MSC), correlation coefficient, graphic 
adjustment, and coherence of values found for the 
velocity constants of each model, using the software 
GraphPad Prism 5 (GraphPad Software Inc.).
%D=100 . (1 - e-kt)      (1)
%D=100 . [1 - (Ae-αt + Be-βt)]  (2)
D=k . t         (3)
D=100 . {1 - e-[(t/td)b]}     (4)
in which: “%D” is the percentage of drug dissolved 
over time “t”; “k”, “α”, and “β” are dissolution kinetic 
constants observed; “A” and “B” are the initial drug 
concentrations that contribute to the two dissolution 
stages; “td” is the time at which 63.2% of the drug are 
dissolved; “b” is the parameter related to the structural 
and geometric characteristics of the pharmaceutical 
product.
Based on the release data achieved, the mechanisms 
involved in the process of drug release from each 
polymeric matrix were also analyzed, using the 
software Scientist® 3.0 for Windows (Micromath®). The 
semi-empirical Korsmeyer-Peppas model19 was used 
to extend the information about the mechanism of 
drug release from the polymeric matrix. This method 
is based on the power law, which exponentially relates 
the drug release with time, and should be applied to 
the first 60% of drug released (Equation 5):
ƒt=a . tn   (5)
in which: “a” is the constant that incorporates 
the structural and geometric characteristics of the 
pharmaceutical product; “n” is the exponent of release 
that indicates the mechanism of release; “ƒt” is the 
drug fraction dissolved at time “t”.
Scanning electron microscopy (SEM)
SEM images of antifungal drugs were obtained 
to complement the other analyses. Small random 
amounts of powder of each antifungal were fixated on 
metallic stubs and sputter-coated with gold-palladium 
using an ion coater (IC-50 Ion Coater; Shimadzu) in 
a vacuum environment. Each sample was assessed 
by SEM (SSX 550 Superscan; Shimadzu) at an 
acceleration voltage of 20 KV, scanning of 100 s, and 
surface area of 25 µm2.16 The most representative 
images were selected to illustrate the characteristics 
of each antifungal.
Results
Confocal laser scanning microscopy (CLSM)
Figures 3 and 4 present CLSM images of specimens 
of all groups in immersion times of 24 h, 7 days, and 14 
days for Softone and Trusoft, respectively. The control 
groups presented similar surface characteristics. At 24 
h, they presented irregular surfaces exhibiting pearls 
and small pores distributed on the surface (Figures 
3A and 4A). At seven days, there was a reduction in 
the quantity of pearls, which were also more subtle; 
conversely, there was an increase in the quantity and 
size of pores on the surface (Figures 3B and 4B). At 14 
days, the surfaces were smoother, yet they presented 
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a swollen aspect (Figures 3C and 3C).
Only groups containing Mc (Figures 3G to 3I and 4G 
to 4I) presented closer features to the control groups, 
yet they presented more irregular surfaces at seven 
days. The specimens modified by the addition of Ny 
still presented pearls and increased quantity and size 
of pores at seven days (Figures 3E and 4E). At 14 days, 
the diameters of pores were increased (Figures 3F and 
4F). For groups with incorporation of Ke, a flat and 
porous surface was observed for Softone specimens at 
Figure 3- CLSM images of tissue conditioner Softone at 24-h (1st column), 7-day (2nd column), and 14-day intervals (3rd column). A to 
C – control; D to F – Ny; G to I – Mc; J to L – Ke; M to O – Chx; and P to R – It. Scale bar = 200 µm (Magnification 10x)
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7-day period (Figure 3K). The Trusoft specimens had 
fewer pearls and more pores at seven days (Figure 
4K). At 14 days, Softone modified by Ke exhibited a 
swollen surface with larger pores (Figure 3L). A flatter 
surface, containing small pores, was observed for 
Trusoft specimens modified by Ke (Figure 4L).
The groups containing Chx and It exhibited the 
greatest changes in surface morphology (Figures 3M 
to 3R and 4M to 4R). Softone modified by Chx had 
more quantity of pores on the surface (Figure 3M). 
Figure 4- CLSM images of resilient liner Trusoft at 24-h (1st column), 7-day (2nd column), and 14-day intervals (3rd column). A to C – 
control; D to F – Ny; G to I – Mc; J to L – Ke; M to O – Chx; and P to R – It. Scale bar = 200 µm (Magnification 10x)
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There was an increase in the amount and size of pores 
at day seven for both materials (Figures 3N and 4N) 
that was greater for Softone (Figure 3N). At 14-day 
period, the surface of Softone was smoother with 
a swollen aspect, yet porous (Figure 3O), and the 
surface of Trusoft was irregular with greater quantity 
of pores (Figure 4O). The specimens with addition of 
It exhibited completely irregular surfaces, containing 
pearls, pores, and spicules at days one (Figures 3P 
and 4P) and seven, that were even more irregular 
at 7-day period (Figures 3Q and 4Q). At day 14, the 
surface was swollen and irregular, exhibiting spicules 
and large pores (Figures 3R and 4R).
The mean roughness (Ra) results are presented 
in Figure 5. Higher roughness values were observed 
in most groups modified by the incorporation of 
antifungals compared with those from the control 
groups at either 7- or 14-day periods (p<0.003). The 
roughness values of Softone and Trusoft specimens 
modified by the addition of Mc as well as of Softone 
specimens modified by Ke were not different from 
those of the control groups (p>0.186) at day 14. 
Except for Softone control group (p=1.000), Ra 
values of all other specimens increased at day seven 
(p<0.026). At the 14-day interval, the roughness 
decreased to values as low as those observed at 24-
hour interval on specimens from control, Ny, Mc, and 
Ke groups (p<0.001). Similar outcome was observed 
on either Softone specimens modified by Chx or on 
Trusoft modified by It (p<0.001). However, Softone 
specimens modified by It and Trusoft modified by Chx 
exhibited higher roughness values than those observed 
at 24 h (p<0.001).
In vitro leachability
The standard calibration curves with the 
corresponding linear regression equations for Chx 
(y=0.0188×+0.0258) and Ny (y=0.0157×+0.0141) 
related the absorbance values in UV-Vis to the 
drug concentration in the samples. The correlation 
coefficients obtained were 0.997 and 0.995 for Chx 
and Ny, respectively.
Figure 5- Mean roughness values (Ra) obtained for Softone and Trusoft in the evaluated groups
Figure 6- In vitro release profiles of Chx (a,b) and Ny (c,d) from Softone and Trusoft, respectively
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Based on the linear equations, the outcomes of 
daily release (µg/mL) of drugs from both materials 
were obtained. The greatest concentration released 
was observed on the first day of analysis. After 14 
days, the tissue conditioner Softone released, on the 
average, 593.3 µg/mL of Chx and 323.6 µg/mL of Ny, 
whereas the resilient liner Trusoft released 521.2 µg/
mL of Chx and 88.2 µg/mL of Ny. Softone leached a 
higher concentration of the antifungals than Trusoft 
(p=0.004), and chlorhexidine was released at a higher 
concentration than nystatin (p<0.001).
The adjusted in vitro release profiles of Chx 
and Ny from Softone and Trusoft were obtained by 
plotting the percentages released with time (Figure 
6). Mathematical modeling data revealed that the 
best kinetics for both materials was explained by the 
biexponential model (Table 1), with the materials 
showing a first stage of fast release (α) and a second 
one of slow or controlled release (β). The n values 
according to the Korsmeyer-Peppas test for Softone 
and Trusoft containing Chx were 0.6 and 0.36, 
respectively, and for the samples containing Ny, the 
n values were 0.22 and 0.29, respectively.
Scanning electron microscopy (SEM)
The SEM images of antifungal particles are 
presented in Figure 7. The smallest particle sizes were 
observed for Ny and Ke. The particles of Ny presented 
irregular morphology and elongated shape with several 
sizes, smaller than 10 µm (Figures 7A and 7B). The 
particles of Ke had very reduced sizes (15 µm) and 
exhibited rounder shapes (Figures 7E and 7F). Mc 
exhibited particles with several sizes up to 200 µm with 
more elongated shape than Ny (Figures 7C and 7D). It 
exhibited higher particles with irregular characteristics, 
with appearance of spicules on its surface, with a 
maximum area of up to 150 µm2 (Figures 7I and 7J). 
Chx exhibited the highest particles, with a smoother 
aspect and a surface area of up to 150 µm2 (Figures 
7G and 7H).
Discussion
This study showed surface changes in both 
materials, especially in groups modified by the addition 
of antifungals and in samples immersed in water for 
longer periods. Therefore, the first hypothesis was 
accepted. One factor associated with the morphological 
surface change of soft materials is related to their 
degradation after immersion in aqueous solutions. 
Studies have reported that the release of alcohol and 
plasticizer in water may lead to an increase in the 
surface roughness of these materials after immersion 
times.20 Moreover, the release of these components, 
which is accompanied by water absorption inside the 
soft material, leads to a loss of surface integrity.21 In 
addition to the inherent material degradation, the drug 
particles released to the medium can leave pores and 
empty spaces, yielding changes in their morphology.
Surface changes were observed with the addition 
of itraconazole, which may be attributed to the greater 
sizes and irregular shapes of its particles (Figures 
7I and 7J), to the greater amount added to the 
materials10 and to the processing of this drug, which 
is commercially available as pellets. Additionally, 
though not measured, the water absorption affected 
its dimensional stability, since the volume increased 
in these modified specimens, which also changed their 
surface characteristics (Figures 3 and 4 – P to R). The 
surface changes of groups containing chlorhexidine 
diacetate and the increased roughness observed for 
the material Trusoft (Figure 5) are consistent with 
previous studies. A previous study showed that a 
tissue conditioner modified by the incorporation of 
chlorhexidine acetate exhibited particles dispersed 
inside the polymeric matrix, which released antifungals 
for extended periods even at low doses.22 Despite the 
larger particle sizes (Figures 7G and 7H), a smaller 
quantity of chlorhexidine diacetate was necessary as 
MIC for the C. albicans biofilm;10 therefore, this drug 
should be considered in the treatment of denture 
stomatitis, because it shows some advantages 
over other antifungals. It presents broad-spectrum 
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Material Drug MSC r α(min-1) β(min-1)
Softone
Chx 3.41 0.991 0.0053 0.3297
Ny 5.45 0.998 17.729 0.0011
Trusoft
Chx 2.50 0.976 0.2389 0.0026
Ny 5.25 0.999 0.0001 0.2967
Table 1- Mathematical modeling by biexponential equation for both materials containing the drugs
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antimicrobial action, reaching bacteria and fungi 
present in the denture biofilm, besides exhibiting 
significant substantivity, which promotes effectiveness 
for longer study periods.23
Even though miconazole presented larger, yet 
finer particles (Figures 7C and 7D), it did not present 
apparent surface change compared to the control 
groups (Figures 3 and 4 – G to I). The modified 
material was more regular and had no pores. This may 
be due to the lower molecular weight of the miconazole 
particle when compared with other antifungals,16 which 
would allow greater diffusibility of this drug inside the 
polymeric matrix, leading to a higher solvation level.24 
Both ketoconazole and nystatin exhibited smaller 
Figure 7- SEM images of drug particles. A and B – Ny; C and D – Mc; E and F – Ke; G and H – Chx; and I and J – It. Scale bars A, C, E, 
G, and I = 10 µm (Magnification 1000x); B and F = 5 µm (Magnification 2400x); and D, H, and J = 50 µm (Magnification 200x)
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particle sizes (Figures 7A and 7B, and 7E and 7F, 
respectively). Particles with smaller amount and size 
may diffuse more easily inside the polymeric matrix. 
Particularly, nystatin was added to the materials using 
the lowest MIC among the antifungals,10 because 
it presents the broader spectrum among available 
antifungals and is considered fungicidal.6
Materials with greater surface roughness may 
present a higher number of yeasts, since they may 
act as a microbial reservoir, increasing the resistance 
to shear forces during brushing.25 Therefore, ideally, 
soft materials for denture bases should present 
smooth surfaces to prevent the formation of biofilm 
and consequent inflammation of the oral mucosa 
and to facilitate hygiene, although roughness is not 
the only property related to microbial adhesion.26 
In our study, the roughness values provided by the 
confocal microscope showed an increase at day 
seven, with a subsequent reduction at 14 days in 
distilled water to values lower than the initial value 
for the control groups and groups modified by the 
addition of nystatin, miconazole, and ketoconazole. 
The reduction in roughness with immersion in water 
may be associated with inherent characteristics of the 
material and to its composition. Immersion in water 
causes loss of soluble components, possibly leading to 
the formation of empty spaces and pores.27 Over time, 
these pores, which are responsible for the roughness, 
increase in size yielding craters; in turn, the edges of 
these craters are probably reduced and the specimens 
become smooth.27
Despite the surface changes observed after 
addition of drugs, micrographs of the control groups 
of soft materials analyzed (Figures 3A to 3C and 4A 
to 4C) show that both materials presented potential 
for utilization as matrices for the addition and release 
of drugs to the intraoral environment, since they are 
permeable to fluids and present porosity, which are 
important factors related to the transportation of 
drug/water through the polymer. Additionally, studies 
have suggested that small changes in the physical 
and mechanical properties after the incorporation of 
antimicrobials, as observed on the surface analyses, 
might not interfere with the clinical performance of 
the materials16 and would not contraindicate their 
utilization due to their advantage concerning the drug 
release, since temporary resilient linings and tissue 
conditioners are used for short periods.
The leachability study was only conducted with the 
modified materials by the addition of chlorhexidine 
diacetate and nystatin, which were highly effective 
in inhibiting the C. albicans biofilm at the lowest 
MICs.10 To be clinically effective, the drug added 
to polymeric systems should be released to the 
medium.8 Both evaluated antifungals were released 
to the aqueous environment during the study period. 
The chlorhexidine diacetate was released at a higher 
concentration than nystatin, and Softone presented 
greater capacity of release than Trusoft; thus the 
second hypothesis was accepted.
Nystatin, when added to the soft linings, presented 
inhibitory activity against C. albicans biofilm at only 
half the required quantity (0.032 g) for chlorhexidine 
diacetate (0.064 g) per gram of material powder.10 
Since a lower concentration was added, a lower 
concentration could then be released. Other studies 
also observed this dose-dependent relationship, 
since the drug concentration released was directly 
proportional to the quantity added to the polymer.9,28,29
Despite exhibiting smaller particles than 
chlorhexidine diacetate (Figures 7A and 7B, and 7G 
and 7H, respectively) that could facilitate its release 
due to the greater surface-area-to-volume ratio, 
nystatin presents greater molecular weight (926.11 
versus 625.56 for chlorhexidine). Drugs with greater 
molecular weight require greater activation energy to 
penetrate and diffuse by the polymeric matrix, and 
that the rate of drug release may be increased by 
reducing its molecular weight.30 In addition to the lower 
concentration and greater molecular weight, nystatin 
also presents low solubility in hydrophilic solvents, 
yielding a slower release from the polymeric matrix.29 
This study employed a solution of distilled water and 
2% sodium lauryl sulfate to immerse the specimens 
containing nystatin. When surfactants were added to 
the medium for immersion of specimens modified by 
the addition of nystatin, we observed an easier release 
with greater concentration of surfactant. In this study, 
the surfactant sodium lauryl sulfate was added to the 
medium above the critical micelle concentration. Above 
this concentration, the surfactant forms micelles that 
may increase the solubility of substances that are 
poorly soluble in water.29 The surfactant also reduces 
the interfacial tension between polymer and dissolution 
medium, increasing the dispersibility of the matrix 
containing the drug, allowing its release. It also acts 
by promoting the entrance of fluid into the matrix, 
then dissolving and creating canals through which the 
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drug may be released. Even with addition of surfactant, 
nystatin was released in low concentrations.
Although the manufacturer does not mention the 
concentration of plasticizers in the materials evaluated 
in  study, according to the literature,21 it is expected 
that the tissue conditioner Softone present a greater 
quantity of plasticizer than that of the resilient liner 
Trusoft. Plasticizers reduce the glass transition 
temperature of the polymer, making the material 
soft.24 The plasticizer molecules, when released to the 
medium, leave pores in the material through which 
the drug may be released. Water absorption of the 
polymeric system, combined to its porous structure, 
allows controlled drug release, which may aid the 
treatment of persistent Candida infections.28 The 
greater release of both drugs from Softone matrix 
compared to Trusoft matrix would make allow the use 
Softone as vehicle for the incorporation and release 
of antifungals for the treatment of denture stomatitis.
The release kinetics of both drugs from the soft 
materials was biexponential, with high initial release 
followed by controlled release for 14 days. Other 
studies also revealed this pattern of release, greater 
in the first 24 h and controlled until the end of the 
study period.8,28,30,31 This release consists of two stages. 
The initial stage comprises an immediate effect (burst 
effect), which probably indicates the release of the 
drug on the material surface. The subsequent release 
may be the outcome of a complex process involving the 
formation of water droplets around the drug particles, 
in osmotically active sites, and the interaction of these 
droplets with the water absorption process28,30 and the 
polymer porosity.
According to the power law of the semi-empirical 
Korsmeyer-Peppas model,19 when the n values are 
lower than 0.43, drug release is controlled by diffusion 
(Fickian transport mechanism). When the n value is 
higher than 0.85, the release is controlled by swelling 
(or erosion) of polymer (case II transport or non-
Fickian transport).32 Intermediate values 0.43<n<0.85 
indicate mixed or abnormal behavior, involving both 
phenomena. The results showed that the mechanisms 
involved in nystatin release from both materials 
respected the Fick law, i.e., they involved only the 
diffusion process. This may be explained by the results 
from a prior study11, in which the addition of nystatin 
did not influence the water sorption and solubility of 
materials after 14 days of evaluation, indicating that 
this drug could be released without change in the fluid 
transport process through the matrices. Concerning 
chlorhexidine, different behaviors were observed 
between matrices: a Fickian transport mechanism 
was observed for the resilient liner Trusoft, and an 
abnormal mechanism was observed for the tissue 
conditioner Softone. Thus, the third hypothesis of 
this study was also accepted. These data may also be 
explained by the findings of a previous investigation,11 
which showed that, after 14 days, only the material 
Softone modified by the incorporation of chlorhexidine 
at the same concentration as  this study exhibited 
greater water sorption than the control groups. This 
indicates that there may have been swelling of the 
polymer, which, combined with the drug diffusion, 
enhanced the chlorhexidine release from Softone. 
Despite the greater drug release from this matrix, 
the subsequent volume change of the material might 
cause problems related to the dimension stability of 
the relined denture, requiring replacement of Softone 
after one week of utilization.
The results of this in vitro study should be 
carefully applied to clinical conditions. This study 
presents limitations, including simulation of the oral 
aqueous medium with salivary flow and renovation, 
and temperature and pH alterations. The addition 
of antifungal drugs in denture base temporary 
soft materials requires a final evaluation of their 
performance by in vivo studies.
Conclusions
1. The tissue conditioner Softone exhibited more 
irregular surface morphology than the resilient liner 
Trusoft. Surface change with the increase in immersion 
time was observed in both materials, especially in 
those containing drugs, in which extremely porous and 
irregular surfaces were observed for groups containing 
chlorhexidine diacetate and itraconazole;
2. The specimens modified by the addition of drugs 
presented higher roughness values when compared 
with the control groups, that increased at 7 days, 
followed by a reduction to values lower than the 
initial ones at 14 days for the control group and those 
containing nystatin, miconazole, and ketoconazole;
3. Both materials presented biexponential release 
kinetics with fast initial release followed by a slower 
release. Softone released a higher concentration of 
drugs than Trusoft and chlorhexidine was released at 
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a higher concentration than nystatin.
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